Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
165.2 USD | +4.33% | -0.49% | -8.31% |
05:34pm | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
05-01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.31% | 8.84B | |
-3.53% | 184B | |
-1.55% | 107B | |
-2.53% | 67.52B | |
+1.63% | 50.06B | |
+10.15% | 45.67B | |
+3.40% | 41B | |
+3.81% | 26.73B | |
+4.38% | 26.47B | |
+15.23% | 25.05B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Repligen : Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 Revenue $108.6M, vs. Street Est of $93.9M